3.500
+0,00%
2026-10-19
Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +334.6% | +95.2% | 2 / 3 | +55.5% | +2.47 pp | +2.02 pp | +5.0% | 1.50 | 6.15 | 1.063 | +55,5% | 29,8 | +457,1% | 6.15 | 12.78 | −51,9% |
| Pts | 12 | 12 | 8 | 12 | 8 | 12 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 3.500 (close price on 2026-10-19)EPS (TTM): 569,3
Financial charts
1.Revenue & growth
VND bn1.063Q2/26
1.Revenue & growth
VND bn1.063Q2/26
2.Profit & growth
VND bn29,9Q2/26
3.Profit mix (Penman)
VND bn49,0Q2/26
4.Margins & cost structure
%7.8%Q2/26
5.Returns & cash cycle
% · days7.0%Q2/26
6.Earnings quality & cash
VND bn-416Q2/26
7.Asset structure
VND bn3.274Q2/26
8.Funding & debt health
VND bn · times3.274Q2/26
9.Revenue backlog
VND bn290Q2/26
10.Valuation
times · %6,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %332Q2/26
Adjusted EPS growth, latest quarter
335%
Average adjusted EPS growth, 3 quarters
95.2%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
28.6%
Source: vnstockData through Q2/26